Fraser Stodart

Fraser Stodart is a seasoned professional in the pharmaceutical industry with extensive experience in emerging markets. Currently serving as Senior Director and Head of Emerging Markets at Biogen since June 2015, Fraser previously held the role of Executive Director for Growth Markets at Eisai EMEA and has contributed significantly to regulatory strategy and product development tailored to the needs of emerging markets across multiple regions. Prior to this, Fraser held various senior positions at Eisai and Pfizer Limited, focusing on emerging market requirements in product development and regulatory submissions. Fraser holds a Bachelor of Science degree in Biochemistry from the University of Stirling, earned between 1985 and 1989.